Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.

The share price of Columbia University's cellular oncology drug developer, backed by Osage University Partners, has doubled since it floated.

University of Oxford has partnered Global Accelerated Ventures to set up a fund and venture studio aimed at challenges arising from climate change.

Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.

Stanford spinout Bolt Biotherapeutics has raised more than twice as much as originally planned in an offering that also provided exits for corporates Pfizer, Novo and Fan Fung.

Immunocore has raised more than $258m in an upsized offering and an additional $15m in a concurrent private placement.

Harvard-linked Sana brought in nearly four times as much in proceeds as originally planned and saw shares surge 40% on the first day of trading.

Fraunhofer Society has participated in a series B round for its solar wafer technology spinout, which also attracted Saudi Aramco.

Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.